Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


In the last decade mesenchymal stem cells (MSC) have been used to safely treat certain immune and inflammatory conditions such as multiple sclerosis (MS).

Scientists have recently completed...

Google has introduced 'wheelchair accessible' routes in transport navigation to make getting around city centres easier for those with mobility needs.

...

While examining human brain tissues, researchers from the University of Alberta and McGill University found that the tissues from people who had multiple sclerosis (MS) contained an extremely high...

The University of Warwick is leading a project to help unemployed people with long-term pain conditions back into work.

...

A study has found that multiple sclerosis (MS) patients with migraine, hyperlipidaemia or more than three comorbidities have an increased risk of relapse.

Comorbid conditions, such as...

Children and adults who spend more time outside are less likely to develop multiple sclerosis (MS) in later life, a US study has suggested.

Although previous studies have highlighted how UV...

A prospective new method of treating patients with multiple sclerosis (MS) has been proposed by researchers of the Mainz University Medical Center in Germany working in cooperation with...

A study released at #ACTRIMS2018 has revealed that patients who experienced relapses after two courses of Lemtrada (alemtuzumab) showed improvement in relapse rate and disability progression after...

Germany recently informed the European Medicines Agency (EMA) that seven patients with multiple sclerosis (MS) had developed immune-mediated inflammation of the brain (encephalitis) during...

Eating fish at least once a week or eating fish one to three times per month in addition to taking daily fish oil supplements may be associated with a reduced risk of multiple sclerosis (MS),...

Pages

Live Chat Software by Click4Assistance UK